Epstein Secrets

(10/22, Cornwell) reports, "Senate Republicans remained skeptical of a possible deal costing trillions of dollars." Senate Appropriations Chairman Shelby told reporters, "I think we're not going anywhere. A lot of talk, no action." The Washington Post <https://vvww.washingtonpost.com/us-policy/2020/10

reuters.com/article/us-health-coronavirus-gilead/gileads-remdesivir-gets-u-s-fda-approval- for-hospitalized-covid-19-patients-idUSICBN2772XQ> (10/22, Beasley) reports that despite positive results from NIH and the new approval, "the World Health Organization (WHO) last week said its global trial of COVID-

verage, which highlighted the FBI's involvement with the investigation of this case. North Carolina Man Found Guilty Of Drug, Firearm Charges. The Shelby (NC) Star (1/22, 42K) reported that North Carolina resident Marcus Isaiah Curry has been found "guilty of four counts of distribution of crack cocai

break from Trump's discursive approach to the pandemic as cases continue to climb nationwide." USA Today (1/24, Rivera, 12.7M) and Politico (1/24, Beasley, 6.73M) also report. US Passes 25M Confirmed Cases; Epidemiologist Pegs Total At More Than 105M. The AP (1/24) says "the new milestone" of 25 milli

s (10/22, Cornwell) reports, "Senate Republicans remained skeptical of a possible deal costing trillions of dollars." Senate Appropriations Chairman Shelby told reporters, "I think we're not going anywhere. A lot of talk, no action." The Washington Post (10/22, Werner, Stein, 14.2M) says some Senate Re

though the FDA "will still allow the drug's use in certain cases under its previous emergency authorization" for patients under 12. Reuters (10/22, Beasley) reports that despite positive results from NIH and the new approval, "the World Health Organization (WHO) last week said its global trial of COVID-

s (10/22, Cornwell) reports, "Senate Republicans remained skeptical of a possible deal costing trillions of dollars." Senate Appropriations Chairman Shelby told reporters, "I think we're not going anywhere. A lot of talk, no action." The Washington Post (10/22, Werner, Stein, 14.2M) says some Senate Re

ough the FDA "will still allow the drug's use in certain cases under its previous emergency authorization" for patients under 12. Retiterc (10/22, Beasley) reports that despite positive results from NIH and the new approval, "the World Health Organization (WHO) last week said its global trial of COVID-